We DO NOT PROVIDE ANY PRODUCTS OR SERVICES DIRECTLY TO PATIENTS. All of our products are for Research Use Only (RUO), NOT intended for diagnostic, therapeutic, or clinical use.
The belongs to the Parapoxvirus genus and causes skin lesions mainly in red deer. Skin lesions provoked by Parapoxvirus of Red Deer show up on animals' heads, necks, and limbs which resulting in pain along with risks of secondary infections and health issues. Most parapoxvirus strains target livestock animals such as sheep and goats, but the Red Deer variant stands out due to its impact on wildlife populations. Infected animals or contaminated environments facilitate the spread of the virus through direct contact with people. Infections tend to clear up independently, but develop into serious conditions involving young animals or those with weakened immune defenses. Red Deer Parapoxvirus demonstrates comparable characteristics with other Parapoxviruses responsible for Orf in sheep and Pseudocowpox in cattle. The study of this virus enables scientists to collect vital data that aids in creating vaccines and antiviral medications, along with wildlife health management practices. Investigating the zoonotic potential of this virus enables humans to shield themselves from possible transmission events that emerge under different circumstances. Creative Biolabs supports the development of antiviral treatments and vaccines, along with diagnostic tools for Parapoxvirus. We provide specialized services to help pharmaceutical companies and wildlife disease research organizations move therapies from laboratory research into clinical trials through valuable data and insights.
Fig.1 Structure of ORFV and PVNZ CBPs homology models.1
In Vitro Antiviral Efficacy Assays
In Vivo Efficacy Studies (Animal Models)
Antigen Detection Assays
Nucleic Acid Detection Assays
Antibody Detection Assays (Serology)
Request a quote
The generation of recombinant proteins from parapoxvirus in red deer involves inserting viral genes into expression vectors, which then express the proteins in bacterial or mammalian host cells. Researchers produce monoclonal antibodies against red deer parapoxvirus by first immunizing animals, then creating hybridomas that select antibodies that target specific viral antigens.
CAT | Product Name |
---|---|
(MPYF-1022-KX634) | Magic™ Parapoxvirus of Red Deer (HL953) SB87_gp083 Recombinant Protein |
(MPYF-1022-KX683) | Magic™ Parapoxvirus of Red Deer (HL953) SB87_gp018 Recombinant Protein |
(MPYF-1022-KX704) | Magic™ Parapoxvirus of Red Deer (HL953) SB87_gp106 Recombinant Protein |
(MPYF-1022-KX602) | Magic™ Parapoxvirus of Red Deer (HL953) SB87_gp001 Recombinant Protein |
CAT | Product Name |
---|---|
(MPYF-1122-KX1499) | Anti-Parapoxvirus of Red Deer SB87_gp082 Monoclonal Antibody (MP-K2299) (Mouse IgG) |
(MPYF-1122-KX1517) | Anti-Parapoxvirus of Red Deer SB87_gp062 Monoclonal Antibody (MP-K2317) (Mouse IgG) |
(MPYF-1122-KX1510) | Anti-Parapoxvirus of Red Deer SB87_gp069 Monoclonal Antibody (MP-K2310) (Mouse IgG) |
(MPYF-1122-KX1489) | Anti-Parapoxvirus of Red Deer SB87_gp094 Monoclonal Antibody (MP-K2289) (Mouse IgG) |
(MPYF-1122-KX1576) | Anti-Parapoxvirus of Red Deer SB87_gp049 Monoclonal Antibody (MP-K2376) (Mouse IgG) |
(MPYF-1122-KX1559) | Anti-Parapoxvirus of Red Deer SB87_gp120 Monoclonal Antibody (MP-K2359) (Mouse IgG) |
Get a Quote Today
1. Vaccine Development: Vaccines made from recombinant parapoxvirus proteins help safeguard red deer and other cervids against infection, which stops wildlife population outbreaks.
2. Diagnostic Tools: Diagnostic tests such as ELISA utilize parapoxvirus-specific recombinant proteins and monoclonal antibodies to detect infections in red deer while monitoring the virus's spread through wild animal populations.
3. Epidemiological Studies: The analysis of parapoxvirus distribution and frequency in red deer populations aids conservation and wildlife health management, particularly near zones where wildlife interacts with livestock.
4. Therapeutic Research: Scientists predict that recombinant proteins or monoclonal antibodies will serve as antiviral treatments for parapoxvirus infections in red deer when outbreaks threaten local wildlife populations.
These companies possess specialized virology expertise, which enables thorough research on multiple viruses, including emerging types such as parapoxvirus. This ensures accurate, high-quality research and results.
High-throughput screening, alongside genomic sequencing and viral culture systems, are essential technologies for conducting virus research. These companies benefit from modern equipment, which enables efficient and precise analysis.
Outsourcing virus research enables companies to rapidly develop antiviral drugs and vaccines, as well as diagnostic tools, which helps to decrease the time needed to launch these solutions against viral outbreaks.
Professional virus research organizations possess expertise in regulatory standards and safety protocols, which guarantees that their research stays within legal and ethical boundaries while working with pathogens and performing clinical trials.
Research costs change based on both the research type and its size. Virus detection and diagnostic testing usually cost less than custom research projects and vaccine or drug development initiatives. Numerous businesses design their pricing models according to individual client requirements.
Numerous businesses focus their operations on developing vaccines through research initiatives. These companies work to detect viral antigens and evaluate vaccine candidates within preclinical and clinical trials for safety and effectiveness determination.
Virus research service providers most often extend their offerings to include comprehensive data analysis and detailed report generation. The service provides interpretation of results alongside recommended next steps while presenting the data in a clear and actionable format for clients.
Reference
We DO NOT PROVIDE ANY PRODUCTS OR SERVICES DIRECTLY TO PATIENTS. All of our products are for Research Use Only (RUO), NOT intended for diagnostic, therapeutic, or clinical use.